Danaher (NYSE:DHR) Stock: Insider Gregory Milosevich Sells 2,100 Shares

Danaher Corporation (NYSE:DHR) EVP Gregory Milosevich sold 2,100 shares of the firm’s stock in a transaction that occurred on Monday, November 9th. The shares were sold at an average price of $230.62, for a total transaction of $484,302.00. Following the sale, the executive vice president directly owned 22,367 shares of the company’s stock, valued at $5,158,277.54. This trade represents a 8.58% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Danaher Stock Performance

Shares of DHR opened at $235.47 on Thursday. The company has a market cap of $165.66 billion, a price-to-earnings ratio of 38.54, a P/E/G ratio of 2.96 and a beta of 0.76. The business’s fifty day simple moving average is $221.67 and its two-hundred day simple moving average is $201.56. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The company has a current ratio of 1.63, a quick ratio of 1.29 and a debt-to-equity ratio of 0.45.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Wednesday, October 21st. The conglomerate reported $2.11 earnings per share for the quarter, topping the consensus estimate of $1.92 by $0.19. Danaher had a return on equity of 11.17% and a net margin of 16.91%. The firm had revenue of $6.55 billion during the quarter, compared to analysts’ expectations of $6.56 billion. During the same quarter in the previous year, the business earned $1.89 earnings per share. The company’s revenue was up 8.3% on a year-over-year basis. Research analysts anticipate that Danaher Corporation will post 8.59 earnings per share for the current fiscal year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th were issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend was Wednesday, September 30th. Danaher’s payout ratio is presently 26.19%.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the stock. Citigroup boosted their target price on shares of Danaher from $230.00 to $270.00 and gave the company a “buy” rating in a research note on Thursday, October 22nd. Robert W. Baird boosted their price target on Danaher from $246.00 to $254.00 and gave the company an “outperform” rating in a research note on Thursday, October 22nd. Morgan Stanley boosted their target price on shares of Danaher from $220.00 to $240.00 and gave the company an “overweight” rating in a research report on Monday, October 12th. Royal Bank Of Canada lifted their price target on shares of Danaher from $215.00 to $250.00 and gave the stock an “outperform” rating in a research note on Monday, October 5th. Finally, Wall Street Zen raised shares of Danaher from a “hold” rating to a “buy” rating in a research report on Monday, October 26th. Eighteen research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $242.91.

Institutional Investors Weigh In On Danaher

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in DHR. Advisors Asset Management Inc. bought a new position in Danaher during the third quarter valued at $1,348,000. Minot DeBlois Advisors LLC boosted its position in shares of Danaher by 1.3% during the third quarter. Minot DeBlois Advisors LLC now owns 7,969 shares of the conglomerate’s stock valued at $1,766,000 after buying an additional 105 shares during the period. Private Wealth Asset Management LLC grew its stake in shares of Danaher by 430.6% during the third quarter. Private Wealth Asset Management LLC now owns 4,860 shares of the conglomerate’s stock valued at $1,119,000 after buying an additional 3,944 shares during the last quarter. one8zero8 LLC grew its position in Danaher by 10.3% in the 3rd quarter. one8zero8 LLC now owns 18,862 shares of the conglomerate’s stock valued at $4,179,000 after acquiring an additional 1,765 shares during the last quarter. Finally, Private Advisor Group LLC lifted its position in shares of Danaher by 110.7% during the third quarter. Private Advisor Group LLC now owns 34,773 shares of the conglomerate’s stock worth $7,704,000 after purchasing an additional 18,266 shares during the last quarter. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Danaher Company Profile

Danaher is a global science and technology company that develops and supplies products and services for biotechnology, life sciences, and diagnostics markets. Its offerings include instruments, reagents, consumables, software, and services used in research, drug development and manufacturing, and clinical testing. The company’s businesses include well-known brands such as Cytiva and Pall in bioprocessing and filtration, Beckman Coulter in laboratory and clinical diagnostics, Cepheid in molecular diagnostics, and Leica Microsystems in microscopy.